NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

Archive for 2019

Treatment of IDA – Oral Iron Therapy

Posted: April 15, 2019.
Category - Medicines Update

A new GGC guideline on the Treatment of Iron Deficiency Anaemia (IDA) is now available on StaffNet

Read More...

Therapeutics Handbook Update April 2019

Posted: April 15, 2019.
Category - Medicines Update

The Adult Therapeutics Handbook content has now been updated and includes the following main changes: New guideline –

Read More...

MHRA Updates Quarter 1 2019

Posted: April 10, 2019.
Category - Medicines Update

Updates from the MHRA for the first quarter of 2019 Drug Safety Update includes:

Read More...

DesmoMelt® dosing advice for paediatrics

Posted: April 10, 2019.
Category - Medicines Update

Children with nocturnal enuresis are initially commenced on DesmoMelt® (desmopressin) 120 micrograms daily. If this dose is ineffective, parents/carers are advised to double the dose to 240 micrograms daily (i.e by taking t...

Read More...

Important: Update re enoxaparin

Posted: April 08, 2019.
Category - Medicines Update

Key points: NHSGGC is switching to Inhixa® pre-filled syringes for all strengths of enoxaparin starting from the 25th March 2019. The safety device on the pre-filled syringe is the same as Arovi®...

Read More...

Polypharmacy App Updated

Posted: April 08, 2019.
Category - Medicines Update

Polypharmacy Mobile App now includes Patient shared decision making tools The Polypharmacy Mobile App which has been available since 2015 has now been updated to include the new version of the 

Read More...

Gluten Free Food Provision in Scotland

Posted: March 25, 2019.
Category - Medicines Update

The Scottish Government’s approach remains that within NHS Scotland, individuals who have an appropriate clinical diagnosis should still be able to access a wide range of staple gluten free foods (GFF) on NHS prescription.  The Depar...

Read More...

SGLT2 Inhibitors - Reports of Fournier’s Gangrene

Posted: March 25, 2019.
Category - Medicines Update

By January 2019, the MHRA had received six Yellow Card reports (four in men and two in wom...

Read More...

Aspirin plus Rivaroxaban in stable CAD

Posted: March 25, 2019.
Category - Medicines Update

Key messages Low dose rivaroxaban (2.5mg twice daily) is now licensed in combination with aspirin for the prevention of atherothrombotic events in adult patients with coronary artery disease (CAD) or symptomatic ...

Read More...

Guideline News Mar 2019

Posted: March 22, 2019.
Category - Medicines Update

New Adult NHSGGC Guidelines now available on StaffNet

Read More...